Search Results - "Fletcher, G.G."

  • Showing 1 - 8 results of 8
Refine Results
  1. 1

    Analysis of Titan's neutral upper atmosphere from Cassini Ion Neutral Mass Spectrometer measurements by Cui, J., Yelle, R.V., Vuitton, V., Waite, J.H., Kasprzak, W.T., Gell, D.A., Niemann, H.B., Müller-Wodarg, I.C.F., Borggren, N., Fletcher, G.G., Patrick, E.L., Raaen, E., Magee, B.A.

    Published in Icarus (New York, N.Y. 1962) (01-04-2009)
    “…In this paper we present an in-depth study of the distributions of various neutral species in Titan's upper atmosphere, between 950 and 1500 km for abundant…”
    Get full text
    Journal Article
  2. 2

    Systemic targeted therapy for her2-positive early female breast cancer: a systematic review of the evidence for the 2014 Cancer Care Ontario systemic therapy guideline by Mates, M, Fletcher, G G, Freedman, O C, Eisen, A, Gandhi, S, Trudeau, M E, Dent, S F

    Published in Current oncology (Toronto) (01-03-2015)
    “…This systematic review addresses the question "What is the optimal targeted therapy for female patients with early-stage human epidermal growth factor receptor…”
    Get full text
    Journal Article
  3. 3

    Systemic adjuvant therapy for adult patients at high risk for recurrent cutaneous or mucosal melanoma: an Ontario Health (Cancer Care Ontario) clinical practice guideline by Petrella, T M, Fletcher, G G, Knight, G, McWhirter, E, Rajagopal, S, Song, X, Baetz, T D

    Published in Current oncology (Toronto) (01-02-2020)
    “…Previous versions of the guideline from the Program in Evidence-Based Care (pebc) at Ontario Health (Cancer Care Ontario) recommended that the use of high-dose…”
    Get full text
    Journal Article
  4. 4

    Liver resection for colorectal cancer metastases by Gallinger, S, Biagi, J J, Fletcher, G G, Nhan, C, Ruo, L, McLeod, R S

    Published in Current oncology (Toronto) (01-06-2013)
    “…Should surgery be considered for colorectal cancer (crc) patients who have liver metastases plus (a) pulmonary metastases, (b) portal nodal disease, or (c)…”
    Get full text
    Journal Article
  5. 5

    Optimal systemic therapy for early breast cancer in women: a clinical practice guideline by Eisen, A, Fletcher, G G, Gandhi, S, Mates, M, Freedman, O C, Dent, S F, Trudeau, M E

    Published in Current oncology (Toronto) (01-03-2015)
    “…The Breast Cancer Disease Site Group of Cancer Care Ontario identified the need for new guidelines for the adjuvant systemic therapy of early-stage breast…”
    Get full text
    Journal Article
  6. 6

    Adjuvant endocrine therapy for early breast cancer: a systematic review of the evidence for the 2014 Cancer Care Ontario systemic therapy guideline by Freedman, O C, Fletcher, G G, Gandhi, S, Mates, M, Dent, S F, Trudeau, M E, Eisen, A

    Published in Current oncology (Toronto) (01-03-2015)
    “…Cancer Care Ontario's Program in Evidence-Based Care (pebc) recently created an evidence-based consensus guideline on the systemic treatment of early breast…”
    Get full text
    Journal Article
  7. 7

    Locoregional therapy of locally advanced breast cancer: a clinical practice guideline by Brackstone, M, Fletcher, G G, Dayes, I S, Madarnas, Y, SenGupta, S K, Verma, S

    Published in Current oncology (Toronto) (01-03-2015)
    “…In female patients with locally advanced breast cancer (labc) and good response to neoadjuvant chemotherapy (nact), including endocrine therapy, what is the…”
    Get full text
    Journal Article
  8. 8

    Adjuvant chemotherapy for early female breast cancer: a systematic review of the evidence for the 2014 Cancer Care Ontario systemic therapy guideline by Gandhi, S, Fletcher, G G, Eisen, A, Mates, M, Freedman, O C, Dent, S F, Trudeau, M E

    Published in Current oncology (Toronto) (01-03-2015)
    “…The Program in Evidence-Based Care (pebc) of Cancer Care Ontario recently created an evidence-based consensus guideline on the systemic treatment of early…”
    Get full text
    Journal Article